The development of HPLC-DAD method for determination of active pharmaceutical ingredient in the potassium 2-((4-amino-5-(morpholinomethyl)-4H-1,2,4-triazol-3-yl)thio) acetate substance

.blurhash-client-img { display: none !important; }

Open Access

|Apr 2019

Authors

Department of Toxicological and Inorganic Chemistry, Zaporizhzhya State Medical University, Zaporizhzhya, Ukraine

Department of Toxicological and Inorganic Chemistry, Zaporizhzhya State Medical University, Zaporizhzhya, Ukraine

Department of Physical and Colloidal Chemistry, Zaporizhzhya State Medical University, Zaporizhzhya, Ukraine

Department of Physical and Colloidal Chemistry, Zaporizhzhya State Medical University, Zaporizhzhya, Ukraine

DOI: https://doi.org/10.2478/cipms-2019-0001 | Journal eISSN: 2300-6676 | Journal ISSN: 2084-980X

Language: English

Page range: 5 - 9

Submitted on: Feb 8, 2018

Accepted on: Apr 30, 2018

Published on: Apr 6, 2019

Published by: Sciendo

In partnership with: Paradigm Publishing Services

Publication frequency: 4 issues per year

Keywords:

Related subjects:

© 2019 Roman Shcherbyna, Volodymyr Parchenko, Boris Varynskyi, Andriy Kaplaushenko, published by Sciendo
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.